Focal segmental glomerular sclerosis (FSGS) in the pediatric population is a challenging and complex disease. This session provides an overview of the pathophysiology and treatment for FSGS, including transplant evaluations, apheresis in the pre-transplant phase, and post-transplant management of FSGS recurrence. The efficacy of low-density lipoprotein (LDL) apheresis in refractory FSGS also is discussed.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 5/25/2024.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.

Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):

Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.

Speaker Disclosures:
There are no speaker disclosures to declare.

Commercial Support:
No commercial support declared.

Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.

ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.

Learning Outcome:
Upon completion of this activity, the leaner will be able to care for the pediatric patient with focal segmental glomerulosclerosis in all stages of treatment.